Soliris 300 MG/30 ML vial 30ML
Ended Awarded
- Contract number
- SPE2DX25F6AGD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $30,136
Award facts
- Contract value 100% obligated
- $30,136.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $30,136.38 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with an ultimate completion date of October 7, 2025. The contract calls for the delivery of Soliris 300 mg/30 mL vials, a specialty pharmaceutical product used in the treatment of certain systemic and rare diseases. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an open basis despite its small business status. The award represents an individual order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at approximately $500 million and extending through November 2026.
DMS Pharmaceutical Group leverages its position as a critical supplier within the federal pharmaceutical supply chain to fulfill specialized medical product requirements for Department of Defense healthcare facilities nationwide. The company's established portfolio demonstrates consistent success in securing delivery orders for high-value pharmaceutical products, including oncology treatments, biologics, and specialty medications. This particular order exemplifies the vendor's role in supporting military medical operations by ensuring timely access to essential pharmaceutical supplies across the federal healthcare system.
Quick answers
Who was awarded contract SPE2DX25F6AGD?
SPE2DX25F6AGD was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 16, 2025.
How much is contract SPE2DX25F6AGD worth?
The government has obligated $30,136 on SPE2DX25F6AGD.
Is contract SPE2DX25F6AGD an order under another contract?
Yes. SPE2DX25F6AGD is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AGD competed?
The extent of competition for SPE2DX25F6AGD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award